borderline significanceP =0.051
Patients with advanced-stage UPSC who received combination therapy demonstrated a lower risk of local recurrence compared with those who received chemotherapy alone with a borderline significance ( P =0.051).
Patients with advanced-stage UPSC who received combination therapy demonstrated a lower risk of local recurrence compared with those who received chemotherapy alone with a borderline significance ( P =0.051).
In the future, there may be significant difference in the larger size of the sample.